Traws Pharma, Inc. · NASDAQ:TRAW
Ayrton Capital LLC's stake in Traws Pharma, Inc. fell to 4.29% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Ayrton Capital LLC's stake in Traws Pharma, Inc. fell to 4.29%, 342,935 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 4.29%
- Shares
- 342,935
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ayrton Capital LLC | 4.29% | 342,935 |
| Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B | 4.29% | 342,935 |
| Waqas Khatri | 4.29% | 342,935 |
Source
Related
- Traws Pharma, Inc.
- Ayrton Capital LLC
- Traws Pharma, Inc. shareholders
- Schedule 13G · Ayrton Capital LLC · Feb 13, 2025
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026
- Schedule 13G/A · Ikarian Capital, LLC · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026